Net loss was S$0.25 million (US$0.19 million) for the six months ended June 30, 2025, compared to net income of S$0.18 million for the same period last year, which is primarily attributed to the lower ...
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully-integrated commercial stage biotechnology company, today announced it has entered into a securities purchase ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback